Menu

Plague Ravaging Madagascar

Nearly four dozen people have died.

Oct 10, 2017
Kerry Grens

WIKIMEDIA, ROCKY MOUNTAIN LABORATORIES, NIAID, NIHIn the past week, public health officials in Madagascar have reported 230 new cases of plague and 17 deaths from the bacterial disease, bringing the outbreak’s total in the past two months to 387 infections and 45 deaths, according to the World Health Organization’s (WHO) update yesterday (October 9). The BBC reports that WHO has delivered more than 1 million doses of antibiotics to combat the outbreak.

Plague is endemic to Madagascar, but the spike in infections in the past two months has surpassed typical annual totals and led to an outbreak designation. “Local authorities and international partners are concerned that the outbreak may further spread as it is already present in several cities, and the plague epidemic season has already started and usually runs from September to April,” says the European Centre for Disease Prevention and Control, in an assessment published yesterday.

The bacterial infection is spread by fleas, although humans can catch it from one another by coming into contacted with infected bodily fluids. Of concern presently is the high percentage of “pneumonic plague” cases—72 percent of the Malagasy outbreak—in which patients’ lungs get infected, because coughing can spread the disease.

According to the BBC, cities in Madagascar have ramped up prevention by setting up rat traps, spraying insecticides, closing schools, and cancelling public events. 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.